The Federal Trade Commission has pursued aggressive and creative expansion of its antitrust enforcement efforts under the Biden administration, and the pharmaceutical industry is no exception. Indeed, in a recent interview,...more
9/9/2024
/ Antitrust Provisions ,
Enforcement ,
Federal Rules of Civil Procedure ,
Federal Trade Commission (FTC) ,
FOIA ,
Patent Infringement ,
Patent Trial and Appeal Board ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Proposed Rules ,
Settlement ,
USPTO